Elisabeth Drucker

580 total citations
11 papers, 413 citations indexed

About

Elisabeth Drucker is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Elisabeth Drucker has authored 11 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Elisabeth Drucker's work include Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers) and RNA Research and Splicing (2 papers). Elisabeth Drucker is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers) and RNA Research and Splicing (2 papers). Elisabeth Drucker collaborates with scholars based in Germany, United States and Austria. Elisabeth Drucker's co-authors include Kurt Krapfenbauer, Stephan Singer, Kai Breuhahn, Kerstin Hölzer, Stéphanie Roessler, Peter Schirmacher, Alessandro Ori‬‬, Esther Herpel, Dietmar Thurnher and Juliane Winkler and has published in prestigious journals such as Nature Communications, American Journal Of Pathology and Oncotarget.

In The Last Decade

Elisabeth Drucker

10 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Drucker Germany 9 234 87 64 47 36 11 413
Tran Diem Nghi Vietnam 11 186 0.8× 77 0.9× 64 1.0× 46 1.0× 23 0.6× 14 424
Majda Haznadar United States 11 322 1.4× 161 1.9× 66 1.0× 64 1.4× 31 0.9× 19 494
Gabriele Anton Germany 8 200 0.9× 85 1.0× 45 0.7× 22 0.5× 52 1.4× 14 413
Elvira Inglese Italy 12 242 1.0× 93 1.1× 63 1.0× 48 1.0× 31 0.9× 20 407
Gizem Gülfidan Türkiye 12 244 1.0× 85 1.0× 71 1.1× 83 1.8× 19 0.5× 23 397
Hong Jin China 16 336 1.4× 64 0.7× 53 0.8× 54 1.1× 38 1.1× 33 597
Heather Ann Brauer United States 11 219 0.9× 119 1.4× 142 2.2× 41 0.9× 61 1.7× 21 409
Robert M. Wollman United States 7 303 1.3× 122 1.4× 96 1.5× 37 0.8× 26 0.7× 10 448
Hirotaka Takizawa Japan 12 166 0.7× 78 0.9× 95 1.5× 50 1.1× 37 1.0× 36 475

Countries citing papers authored by Elisabeth Drucker

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Drucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Drucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Drucker more than expected).

Fields of papers citing papers by Elisabeth Drucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Drucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Drucker. The network helps show where Elisabeth Drucker may publish in the future.

Co-authorship network of co-authors of Elisabeth Drucker

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Drucker. A scholar is included among the top collaborators of Elisabeth Drucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Drucker. Elisabeth Drucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Drucker, Elisabeth, Sofia M.E. Weiler, Daniel Dauch, et al.. (2022). HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1. Cancers. 14(2). 459–459. 9 indexed citations
2.
Hölzer, Kerstin, Alessandro Ori‬‬, Amy Cooke, et al.. (2019). Nucleoporin Nup155 is part of the p53 network in liver cancer. Nature Communications. 10(1). 2147–2147. 31 indexed citations
3.
Drucker, Elisabeth, Kerstin Hölzer, Stefan Pusch, et al.. (2019). Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer. Cell Communication and Signaling. 17(1). 159–159. 33 indexed citations
4.
Hölzer, Kerstin, Elisabeth Drucker, Nina Waldburger, et al.. (2018). Ganglioside GM2 activator (GM2A) is as a novel pro-survival p53 target in hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 56(1). E2–E89.
5.
Hölzer, Kerstin, Elisabeth Drucker, Stéphanie Roessler, et al.. (2016). Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer. American Journal Of Pathology. 187(2). 228–235. 29 indexed citations
6.
7.
Hölzer, Kerstin, Elisabeth Drucker, Scott C. N. Oliver, et al.. (2016). Cellular apoptosis susceptibility (CAS) is overexpressed in thyroid carcinoma and maintains tumor cell growth: A potential link to the BRAFV600E mutation. International Journal of Oncology. 48(4). 1679–1687. 10 indexed citations
8.
Hölzer, Kerstin, Elisabeth Drucker, Stéphanie Roessler, et al.. (2016). Guanine monophosphate synthetase (GMPS) is an important target of p53-mediated repression in liver cancer. Zeitschrift für Gastroenterologie. 54(12). 1343–1404. 1 indexed citations
9.
Winkler, Juliane, Stéphanie Roessler, Carsten Sticht, et al.. (2016). Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC). Oncotarget. 7(16). 22883–22892. 17 indexed citations
10.
Krapfenbauer, Kurt, Elisabeth Drucker, & Dietmar Thurnher. (2014). Identification of tumour-related proteins as potential screening markers by proteome analysis—protein profiles of human saliva as a predictive and prognostic tool. The EPMA Journal. 5(1). 20–20. 20 indexed citations
11.
Drucker, Elisabeth & Kurt Krapfenbauer. (2013). Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. The EPMA Journal. 4(1). 7–7. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026